Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

Author:

Lichtenstein Gary R,Feagan Brian G,Cohen Russell D,Salzberg Bruce A,Diamond Robert H,Price Samiyeh,Langholff Wayne,Londhe Anil,Sandborn William J

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. Emerging prognostic markers to determine Crohns disease natural history and improve management strategies: a review of recent literature.;Lichtenstein;Gastroenterol Hepatol (NY),2010

2. How do patients with inflammatory bowel disease want their biological therapy administered?;Allen;BMC Gastroenterol,2010

3. Tumor necrosis factor- monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology.;Lee;Gastroenterol Clin North Am,2010

4. Efficacy of TNF antagonists beyond one year in adult and pediatric inflammatory bowel diseases: a systematic review.;Oussalah;Curr Drug Targets,2010

5. What is the optimal therapy for Crohns disease: step-up or top-down?;Lin;Expert Rev Gastroenterol Hepatol,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3